Sosyal kuruluşlar için hibeler ve destekler

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Amerika Birleşik Devletleri · US

Kimler başvurabilir Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · Small businesses · Independent school districts · Private institutions of higher education · County governments · State governments · For profit organizations other than small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal organizations (other than Federally recognized tribal governments)

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)

Amerika Birleşik Devletleri · US

Kimler başvurabilir Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · State governments · City or township governments · Special district governments · Native American tribal governments (Federally recognized) · County governments

The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications that improve health. It encourages high quality science demonstrating the potential to result in understanding an important disease process or lead to new therapeutic interventions, diagnostics, or prevention strategies within the research interests and priorities of the participating NIH Institutes/Centers (ICs).Specifically, the program seeks to broaden and strengthen translational research collaborations between basic and clinical researchers both within and outside NIH to accelerate and enhance translational science by promoting partnerships between NIH intramural investigators (e.g., those conducting research within the labs and clinics of the NIH) and extramural investigators (e.g., those conducting research in labs outside the NIH), and by providing support for extramural investigators to take advantage of the unique research opportunities available at the NIH Clinical Center by conducting clinical research projects in collaboration with NIH intramural investigators.

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Amerika Birleşik Devletleri · US

Kimler başvurabilir City or township governments · Small businesses · Special district governments · Public housing authorities/Indian housing authorities · County governments · State governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public and State controlled institutions of higher education · For profit organizations other than small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

NEA Sanat ve Eserler Uluslararası Tazminat Programı 2, FY2027 (3/27)

Amerika Birleşik Devletleri · US

Kimler başvurabilir County governments · State governments · Public and State controlled institutions of higher education · Independent school districts · Special district governments · Native American tribal governments (Federally recognized) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · Private institutions of higher education

Daha fazla bilgi için arts.gov adresindeki başvuru yönergelerine ve talimatlarına bakın.

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Amerika Birleşik Devletleri · US

Kimler başvurabilir State governments · Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · For profit organizations other than small businesses · County governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Special district governments · Independent school districts · City or township governments · Public and State controlled institutions of higher education

The NIH Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) was created to improve research on type 1 diabetes (T1D) and cardiovascular disease (CVD). Cardiovascular complications remain the top cause of death among people with T1D and greatly shorten lifespan. The mechanisms underlying atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy in T1D remain poorly understood. While managing traditional risk factors—such as high blood glucose, high blood pressure, and elevated cholesterol lower cardiovascular risk, a significant residual risk remains even with optimal control. In addition to atherosclerosis, both diastolic and systolic diabetic cardiomyopathy play a major role in morbidity and mortality among these patients. Currently, no therapies are specifically approved to prevent or treat these common and severe cardiovascular issues in T1D. The purpose of this NOFO is to promote collaborative and interdisciplinary research aimed at enhancing the understanding of the development of CVD in individuals with T1D and the differences with CVD in T1D by continuing the efforts of the CaRe-T1D consortium.This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.

Pillar I: Facilitating development of institutional open access policies through the retention of intellectual property rights

Avrupa Birliği · EU

Pillar I: Facilitating development of institutional open access policies through the retention of intellectual property rights

Dönem: 8/12/2026 – —

Pillar II: Talent ecosystems for attractive early research careers

Avrupa Birliği · EU

Pillar II: Talent ecosystems for attractive early research careers

Dönem: 8/12/2026 – —

Pillar III: Science comes to town 2029

Avrupa Birliği · EU

Pillar III: Science comes to town 2029

Dönem: 8/12/2026 – —

Pillar III: Promoting public engagement in R&I and scientific literacy

Avrupa Birliği · EU

Pillar III: Promoting public engagement in R&I and scientific literacy

Dönem: 8/12/2026 – —

Pillar IV: Upgrading the EU’s independent knowledge on China's Science, Technology and Innovation system

Avrupa Birliği · EU

Pillar IV: Upgrading the EU’s independent knowledge on China's Science, Technology and Innovation system

Dönem: 8/12/2026 – —

Förderung von Forschungsvorhaben „Plattform Privatheit – IT-Sicherheit schützt Privatheit und stützt Demokratie“

Almanya · DE

Wenn Sie die Herausforderungen des verantwortungsbewussten Umgangs mit digitaler Technologie erforschen, können Sie unter bestimmten Voraussetzungen einen Zuschuss erhalten.

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Amerika Birleşik Devletleri · US

Kimler başvurabilir Private institutions of higher education · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Special district governments · State governments · Public housing authorities/Indian housing authorities · Small businesses · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · For profit organizations other than small businesses · Independent school districts · County governments

This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research for people who use drugs. For the purposes of this NOFO, "intervention" may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection, or improve clinical outcomes for persons living with HIV.

New approaches for decentralized, federated and sustainable AI data processing (RIA)

Avrupa Birliği · EU

New approaches for decentralized, federated and sustainable AI data processing (RIA)

Dönem: 17/11/2026 – —

Demand-side 3C pilot demonstrators on converged Telco Edge Cloud Infrastructure (IA)

Avrupa Birliği · EU

Demand-side 3C pilot demonstrators on converged Telco Edge Cloud Infrastructure (IA)

Dönem: 17/11/2026 – —

Energy efficiency and sustainability of AI data processing in Data Centres (IA)

Avrupa Birliği · EU

Energy efficiency and sustainability of AI data processing in Data Centres (IA)

Dönem: 17/11/2026 – —

Apply AI: Challenge-Driven AI Innovation Booster in Apply AI prioritised sectors (RIA) (Partnership in AI, Data and Robotics)

Avrupa Birliği · EU

Apply AI: Challenge-Driven AI Innovation Booster in Apply AI prioritised sectors (RIA) (Partnership in AI, Data and Robotics)

Dönem: 17/11/2026 – —

Apply AI: AI-Driven Robotics for Industry: Enabling System Integration and Adoption (IA) (Partnership in AI, Data and Robotics)

Avrupa Birliği · EU

Apply AI: AI-Driven Robotics for Industry: Enabling System Integration and Adoption (IA) (Partnership in AI, Data and Robotics)

Dönem: 17/11/2026 – —

International cooperation in AI (IA)

Avrupa Birliği · EU

International cooperation in AI (IA)

Dönem: 17/11/2026 – —

Horizon scanning and foresight in future enabling digital technologies (CSA)

Avrupa Birliği · EU

Horizon scanning and foresight in future enabling digital technologies (CSA)

Dönem: 17/11/2026 – —

EU Frontier AI Initiative: Developing frontier AI solutions that are safe and computationally efficient within Apply AI (RIA)

Avrupa Birliği · EU

EU Frontier AI Initiative: Developing frontier AI solutions that are safe and computationally efficient within Apply AI (RIA)

Dönem: 17/11/2026 – —

Advanced and Innovative hardware components for Virtual Worlds (RIA) (Virtual Worlds Partnership)

Avrupa Birliği · EU

Advanced and Innovative hardware components for Virtual Worlds (RIA) (Virtual Worlds Partnership)

Dönem: 17/11/2026 – —

Create a thriving and competitive Virtual Worlds and Web 4.0 ecosystem (CSA) (Virtual Worlds Partnership)

Avrupa Birliği · EU

Create a thriving and competitive Virtual Worlds and Web 4.0 ecosystem (CSA) (Virtual Worlds Partnership)

Dönem: 17/11/2026 – —

Facilitate the engagement of European stakeholders in international digital standardisation (CSA)

Avrupa Birliği · EU

Facilitate the engagement of European stakeholders in international digital standardisation (CSA)

Dönem: 17/11/2026 – —

Advanced integrated photonic devices for extended features and ultra-low power consumption (RIA) (Photonics Partnership)

Avrupa Birliği · EU

Advanced integrated photonic devices for extended features and ultra-low power consumption (RIA) (Photonics Partnership)

Dönem: 17/11/2026 – —